Divis Laboratories Ltd | DIVI - Ebitda

Stock Price
6,143.00
Daily Change
-66.00 -1.06%
Monthly
-3.47%
Yearly
0.77%
Q1 Forecast
5,937.24

Divis Laboratories Ltd reported INR8.88B in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Aurobindo Pharma INR 16.78B 751M Sep/2025
Avita Medical AUD -21.9M 12.04M Jun/2025
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Divis Laboratories Ltd INR 8.88B 1.59B Sep/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
IQVIA Holdings USD 949M 39M Sep/2025
Lupin INR 23.41B 6.14B Sep/2025
Moderna USD -208M 552M Sep/2025
Organon & Co USD 518M 4M Sep/2025
Revvity USD 248.91M 48.52M Dec/2025
Tectonic Therapeutic USD -13.48M 5.73M Dec/2024
Tilray USD 8.36M 1.82M Sep/2025
Viatris USD 1.15B 75.8M Sep/2025
Xeris Pharmaceuticals USD 17.42M 8.83M Sep/2025